Transdermal Sensing of Enzyme Biomarker Enabled by Chemo‐Responsive Probe‐Modified Epidermal Microneedle Patch in Human Skin Tissue
Advanced Materials · 2024-07 · 36 (30)
DOI: 10.1002/adma.202403758 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 19.05.2024. Verfasst von Nazanin Poursharifi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Solna, Division of Dermatology and Venereology, Karolinska Institutet, Stockholm, 171 77, Sweden. Hauptthemen laut MEDLINE: Needles, Monophenol Monooxygenase, Wearable Electronic Devices. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Karolinska Institutet.
Abstract (Originalsprache)
Wearable bioelectronics represents a significant breakthrough in healthcare settings, particularly in (bio)sensing which offers an alternative way to track individual health for diagnostics and therapy. However, there has been no notable improvement in the field of cancer, particularly for skin cancer. Here, a wearable bioelectronic patch is established for transdermal sensing of the melanoma biomarker, tyrosinase (Tyr), using a microneedle array integrated with a surface‐bound chemo‐responsive smart probe to enable target‐specific electrochemical detection of Tyr directly from human skin tissue. The results presented herein demonstrate the feasibility of a transdermal microneedle sensor for direct quantification of enzyme biomarkers in an ex vivo skin model. Initial performance analysis of the transdermal microneedle sensor proves that the designed methodology can be an alternative for fast and reliable diagnosis of melanoma and the evaluation of skin moles. The innovative approach presented here may revolutionize the landscape of skin monitoring by offering a nondisruptive means for continuous surveillance and timely intervention of skin anomalies, such as inflammatory skin diseases or allergies and can be extended to the screening of multiple responses of complementary biomarkers with simple modification in device design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Solna, Division of Dermatology and Venereology, Karolinska Institutet, Stockholm, 171 77, Sweden.
- Department of Dermatology and Allergy, TUM School of Medicine and Health, Technical University of Munich, 80802, Munich, Germany.
- Department of Analytical Chemistry, Faculty of Pharmacy, İzmir Katip Çelebi University, İzmir, 35620, Türkiye.
- Center for the Advancement of Integrated Medical and Engineering Sciences, Karolinska Institutet and KTH Royal Institute of Technology, Stockholm, 171 77, Sweden.
- Centre for Molecular Medicine, Karolinska University Hospital, Stockholm, 171 64, Sweden.
ORCID-Profile: Onur Parlak
Förderung
- Vetenskapsrådet
- Karolinska Institutet
Zitieren
APA
Poursharifi, N., Hassanpouramiri, M., Zink, A., Ucuncu, M., & Parlak, O. (2024). Transdermal Sensing of Enzyme Biomarker Enabled by Chemo‐Responsive Probe‐Modified Epidermal Microneedle Patch in Human Skin Tissue. Advanced Materials, 36(30). https://doi.org/10.1002/adma.202403758
Vancouver
Poursharifi N, Hassanpouramiri M, Zink A, Ucuncu M, Parlak O. Transdermal Sensing of Enzyme Biomarker Enabled by Chemo‐Responsive Probe‐Modified Epidermal Microneedle Patch in Human Skin Tissue. Advanced Materials. 2024;36(30). doi:10.1002/adma.202403758
BibTeX
@article{Poursharifi2024,
author = {Poursharifi, Nazanin and Hassanpouramiri, Morteza and Zink, Alexander and Ucuncu, Muhammed and Parlak, Onur},
title = {Transdermal Sensing of Enzyme Biomarker Enabled by Chemo‐Responsive Probe‐Modified Epidermal Microneedle Patch in Human Skin Tissue},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {30},
doi = {10.1002/adma.202403758}
}
EUVIMED